Nivolumab

Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
Lucie Heinzerling, Patrick A. Ott, F. Stephen Hodi, Aliya N. Husain, Azadeh Tajmir-Riahi, Hussein Tawbi, Matthias Pauschinger, Thomas F. Gajewski, Evan J. Lipson, Jason J. Luke

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 50; DOI: 10.1186/s40425-016-0152-y
Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody
Mehmet Asim Bilen, Sumit K. Subudhi, Jianjun Gao, Nizar M. Tannir, Shi-Ming Tu, Padmanee Sharma

Journal for ImmunoTherapy of Cancer Dec 2016, 4 (1) 36; DOI: 10.1186/s40425-016-0139-8

Main menu